Compare DX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DX | ATRC |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | DX | ATRC |
|---|---|---|
| Price | $13.88 | $40.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $13.83 | ★ $52.22 |
| AVG Volume (30 Days) | ★ 4.2M | 530.6K |
| Earning Date | 01-26-2026 | 02-11-2026 |
| Dividend Yield | ★ 14.62% | N/A |
| EPS Growth | ★ 35.65 | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | $230,447,000.00 | ★ $518,304,999.00 |
| Revenue This Year | N/A | $16.90 |
| Revenue Next Year | $134.14 | $12.29 |
| P/E Ratio | $8.41 | ★ N/A |
| Revenue Growth | ★ 87.09 | 15.80 |
| 52 Week Low | $10.79 | $28.29 |
| 52 Week High | $14.52 | $43.11 |
| Indicator | DX | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 58.53 |
| Support Level | $13.81 | $40.11 |
| Resistance Level | $13.98 | $41.92 |
| Average True Range (ATR) | 0.18 | 1.23 |
| MACD | 0.00 | -0.14 |
| Stochastic Oscillator | 69.83 | 44.02 |
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.